Open Access

Erratum to: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice

Contributed equally
Genetic Vaccines and Therapy20097:3

DOI: 10.1186/1479-0556-7-3

Received: 28 January 2009

Accepted: 4 February 2009

Published: 4 February 2009

The original article was published in Genetic Vaccines and Therapy 2008 6:13

Correction

Since publication of our article [1], it has come to our attention that the alpha-myosin heavy chain promoter was incorrectly identified as being of human origin. The correct origin of the promoter was from mouse.

The corrections within the text are as follows:

Under the heading Findings, 5 paragraph, line 3: "human alpha-myosin heavy chain" should be "murine alpha-myosin heavy chain."

Under the heading Findings, 8th paragraph, line 1: "The human a-MHC promoter" should be "The murine a-MHC promoter"

Figure 1, Figure legend, line 6; "...created by amplifying human genomic DNA" should be "... created by amplifying mouse genomic DNA."

The authors regret the error and any inconveniences to the readers. The results and conclusions of this article remain unchanged.

Notes

Authors’ Affiliations

(1)
Powell Gene Therapy Center, College of Medicine, University of Florida

References

  1. Pacak CA, Sakai Y, Thattaliyath BD, Mah CS, Byrne BJ: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice. Genetic Vaccines and Therapy. 2008, 6: 13. 10.1186/1479-0556-6-13.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Pacak et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement